Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?
Oriola Q4’24: Write-down weighed on reported earnings

Af Rauli Juva
Oriola's Q4 earnings were largely in line with expectations, but the reported earnings were weighed down by the previously announced write-down. The company guides for improved earnings this year. Oriola's CEO Katarina Gabrielson interviewed by analyst Rauli Juva.
Topics:
00:00 Intro
00:09 Operating model renewal and changes in the management team
02:19 MedInfo acquisition
03:58 Earnings on par with the comparison period excluding Swedish dose dispensing
04:35 Pharmacy joint venture's result was negative
05:07 Dividend policy
05:56 Change in guidance
06:53 Drivers for 2025
07:25 Reaching profitability levels comparable to Kronans Apotek's industry